Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra Hanna

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Bulletin of the World Health Organization|November 14, 2023
Target product profiles: tests for tuberculosis treatment monitoring and optimizationAnkur Gupta-Wright, Saskia den Boon, Emily L MacLean, et al.
Scientific Reports|February 22, 2020
Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
Scientific Reports|October 20, 2018
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
A class of selective antibacterials derived from a protein kinase inhibitor pharmacophoreJ Richard Miller, Steve Dunham, Igor Mochalkin, et al.
Journal of Medicinal Chemistry|November 9, 2007
Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compoundToni-Jo Poel, Richard C Thomas, Wade J Adams, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
Bulletin of the World Health Organization|July 29, 2024
Target regimen profiles for tuberculosis treatmentChristian Lienhardt, Kelly E Dooley, Payam Nahid, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Bulletin of the World Health Organization|November 14, 2023
Target product profiles: tests for tuberculosis treatment monitoring and optimizationAnkur Gupta-Wright, Saskia den Boon, Emily L MacLean, et al.
Scientific Reports|February 22, 2020
Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
Scientific Reports|October 20, 2018
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
A class of selective antibacterials derived from a protein kinase inhibitor pharmacophoreJ Richard Miller, Steve Dunham, Igor Mochalkin, et al.
Journal of Medicinal Chemistry|November 9, 2007
Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compoundToni-Jo Poel, Richard C Thomas, Wade J Adams, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
Bulletin of the World Health Organization|July 29, 2024
Target regimen profiles for tuberculosis treatmentChristian Lienhardt, Kelly E Dooley, Payam Nahid, et al.
Pageof 4